Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4794)
All Articles published online
|
Aug 28, 2006 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cervello M, Montalto G. Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol 2006; 12(32): 5113-5121 [PMID: 16937518 DOI: 10.3748/wjg.v12.i32.5113] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i32/5113.htm |
| Number | Citing Articles |
| 1 |
Shanshan Wang, Ting Lei, Man Zhang, Ferenc Gallyas. The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer. PLOS ONE 2016; 11(7): e0157759 doi: 10.1371/journal.pone.0157759
|
| 2 |
Monika Berbecka, Alicja Forma, Jacek Baj, Marzena Furtak-Niczyporuk, Ryszard Maciejewski, Robert Sitarz. A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy. Journal of Clinical Medicine 2021; 10(19): 4443 doi: 10.3390/jcm10194443
|
| 3 |
Martins Ekor, Adesina O. Odewabi, Oluwafemi E. Kale, Omolola A. Adesanoye, Titilayo O. Bamidele. Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride–associated hepatotoxicity in rats. Drug and Chemical Toxicology 2013; 36(1): 1 doi: 10.3109/01480545.2011.642380
|
| 4 |
Susan Li Er Loong, Jacqueline Siok Gek Hwang, Hui Hua Li, Joseph Tien Seng Wee, Swee Peng Yap, Melvin Lee Kiang Chua, Kam Weng Fong, Terence Wee Kiat Tan. Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01). Radiation Oncology 2009; 4(1) doi: 10.1186/1748-717X-4-23
|
| 5 |
Daniel J. Luther, Vahagn Ohanyan, Patricia E. Shamhart, Cheryl M. Hodnichak, Hamayak Sisakian, Tristan D. Booth, J. Gary Meszaros, Anupam Bishayee. Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma. Investigational New Drugs 2011; 29(2): 380 doi: 10.1007/s10637-009-9332-7
|
| 6 |
Yuko Takami, Susumu Eguchi, Masaki Tateishi, Tomoki Ryu, Kazuhiro Mikagi, Yoshiyuki Wada, Hideki Saitsu. A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment. Hepatology International 2016; 10(5): 799 doi: 10.1007/s12072-016-9704-y
|
| 7 |
Yuan Cao, Ming Zhao, Yue Zhu, Zhen-Hua Zhu, Lukas Oberer, Jin-Ao Duan. Diselaginellin B, an Unusual Dimeric Molecule from Selaginella pulvinata, Inhibited Metastasis and Induced Apoptosis of SMMC-7721 Human Hepatocellular Carcinoma Cells. Journal of Natural Products 2017; 80(12): 3151 doi: 10.1021/acs.jnatprod.7b00404
|
| 8 |
Lydia Giannitrapani, Maurizio Soresi, Sabrina Ingrao, Emanuele La Spada, Onofrio Vuturo, Ada Maria Florena, Melchiorre Cervello, Giuseppe Montalto. Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2007; 19(11): 927 doi: 10.1097/MEG.0b013e3282f01e91
|
| 9 |
Dingbo Shi, Xiangsheng Xiao, Yun Tian, Lijun Qin, Fangyun Xie, Rui Sun, Jingshu Wang, Wenbin Li, Tianze Liu, Yao Xiao, Wendan Yu, Wei Guo, Yuqing Xiong, Huijuan Qiu, Tiebang Kang, Wenlin Huang, Chong Zhao, Wuguo Deng. Activating enhancer-binding protein-2α induces cyclooxygenase-2 expression and promotes nasopharyngeal carcinoma growth. Oncotarget 2015; 6(7): 5005 doi: 10.18632/oncotarget.3215
|
| 10 |
Nelson Alexandre Kretzmann, Eduardo Chiela, Ursula Matte, Norma Marroni, Claudio Augusto Marroni. N-acetylcysteine improves antitumoural response of Interferon alpha by NF-kB downregulation in liver cancer cells. Comparative Hepatology 2012; 11(1) doi: 10.1186/1476-5926-11-4
|
| 11 |
Shaimaa Almohaid, Saeed Akhtar. Diet, lifestyle factors, comorbidities, and hepatocellular carcinoma risk in a middle eastern country: a case-control study. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12409-0
|
| 12 |
Mudan Ren, Eileen McGowan, Yarui Li, Xiaofeng Zhu, Xinlan Lu, Zhanfang Zhu, Yiguang Lin, Shuixiang He. Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ Signaling Pathway in Liver Cancer: A Novel Mechanism of Action. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00623
|
| 13 |
Hitomi Hayashi, Eriko Taniai, Reiko Morita, Atsunori Yafune, Kazuhiko Suzuki, Makoto Shibutani, Kunitoshi Mitsumori. Threshold dose of liver tumor promoting effect of β-naphthoflavone in rats. The Journal of Toxicological Sciences 2012; 37(3): 517 doi: 10.2131/jts.37.517
|
| 14 |
Fei Yu, Kai Li, Suning Chen, Yunpeng Liu, Yan Li. Pseudolaric Acid B Circumvents Multidrug Resistance Phenotype in Human Gastric Cancer SGC7901/ADR Cells by Downregulating Cox-2 and P-gp Expression. Cell Biochemistry and Biophysics 2015; 71(1): 119 doi: 10.1007/s12013-014-0170-7
|
| 15 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_186-1
|
| 16 |
Maria Narożna, Violetta Krajka-Kuźniak, Barbara Bednarczyk-Cwynar, Małgorzata Kucińska, Robert Kleszcz, Jacek Kujawski, Hanna Piotrowska-Kempisty, Adam Plewiński, Marek Murias, Wanda Baer-Dubowska. Conjugation of Diclofenac with Novel Oleanolic Acid Derivatives Modulate Nrf2 and NF-κB Activity in Hepatic Cancer Cells and Normal Hepatocytes Leading to Enhancement of Its Therapeutic and Chemopreventive Potential. Pharmaceuticals 2021; 14(7): 688 doi: 10.3390/ph14070688
|
| 17 |
Antonella Cusimano, Daniele Balasus, Antonina Azzolina, Giuseppa Augello, Maria R. Emma, Caterina Di Sano, Roberto Gramignoli, Stephen C. Strom, James A. Mccubrey, Giuseppe Montalto, Melchiorre Cervello. Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation. International Journal of Oncology 2017; 51(2): 533 doi: 10.3892/ijo.2017.4049
|
| 18 |
Melchiorre Cervello, Dimcho Bachvarov, Nadia Lampiasi, Antonella Cusimano, Antonina Azzolina, James A. McCubrey, Giuseppe Montalto, Manlio Vinciguerra. Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells. PLoS ONE 2013; 8(6): e65569 doi: 10.1371/journal.pone.0065569
|
| 19 |
Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum, Erik A. Rauws, B.W. Marcel Spanier, Alexander C. Poen, Karin M. van Nieuwkerk, Joost P. Drenth, Ben J. Witteman, Hans A. Tuynman, Anton H. Naber, Paul J. Kingma, Henk R. van Buuren, Bart van Hoek, Frank P. Vleggaar, Nan van Geloven, Ulrich Beuers, Cyriel Y. Ponsioen. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013; 58(6): 2045 doi: 10.1002/hep.26565
|
| 20 |
Ş. Küçükgüzel, İnci Coşkun, Sevil Aydın, Göknur Aktay, Şule Gürsoy, Özge Çevik, Özlem Özakpınar, Derya Özsavcı, Azize Şener, Neerja Kaushik-Basu, Amartya Basu, Tanaji Talele. Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-Inflammatory, Analgesic, Antioxidant, Anticancer and Anti-HCV Agents. Molecules 2013; 18(3): 3595 doi: 10.3390/molecules18033595
|
| 21 |
Yu Sun, Jie Chen, Basil Rigas. Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death. Carcinogenesis 2009; 30(1): 93 doi: 10.1093/carcin/bgn242
|
| 22 |
Isabel Fabregat. Dysregulation of apoptosis in hepatocellular carcinoma cells. World Journal of Gastroenterology 2009; 15(5): 513-520 doi: 10.3748/wjg.15.513
|
| 23 |
Jennifer K. Mulligan, Steven A. Rosenzweig, M. Rita I. Young. Tumor Secretion of VEGF Induces Endothelial Cells to Suppress T cell Functions Through the Production of PGE2. Journal of Immunotherapy 2010; 33(2): 126 doi: 10.1097/CJI.0b013e3181b91c9c
|
| 24 |
Anupam Bishayee. Inflammation and Cancer. Advances in Experimental Medicine and Biology 2014; 816: 401 doi: 10.1007/978-3-0348-0837-8_16
|
| 25 |
Andrea J. Moreira, Graziella Rodrigues, Silvia Bona, Carlos Thadeu Cerski, Claudio A. Marroni, Jose L. Mauriz, Javier González-Gallego, Norma P. Marroni. Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats. Toxicology Reports 2015; 2: 333 doi: 10.1016/j.toxrep.2014.11.015
|
| 26 |
Maria Narożna, Violetta Krajka-Kuźniak, Barbara Bednarczyk-Cwynar, Wanda Baer-Dubowska. Unlocking the Potential: Novel NSAIDs Hybrids Unleash Chemopreventive Power toward Liver Cancer Cells through Nrf2, NF-κB, and MAPK Signaling Pathways. Molecules 2023; 28(15): 5759 doi: 10.3390/molecules28155759
|
| 27 |
Tian-Huei Chu, Hoi-Hung Chan, Hsiao-Mei Kuo, Li-Fen Liu, Tsung-Hui Hu, Cheuk-Kwan Sun, Mei-Lang Kung, Shih-Wei Lin, E-Ming Wang, Yi-Ling Ma, Kwan-Hung Cheng, Kwok Hung Lai, Zhi-Hong Wen, Ping-I Hsu, Ming-Hong Tai. Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. Oncotarget 2014; 5(6): 1475 doi: 10.18632/oncotarget.1745
|
| 28 |
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular Carcinoma. The Anatomical Record 2008; 291(6): 721 doi: 10.1002/ar.20668
|
| 29 |
Ola M Tork, Eman F Khaleel, Omnia M Abdelmaqsoud. Altered Cell to Cell Communication, Autophagy and Mitochondrial Dysfunction in a Model of Hepatocellular Carcinoma: Potential Protective Effects of Curcumin and Stem Cell Therapy. Asian Pacific Journal of Cancer Prevention 2016; 16(18): 8271 doi: 10.7314/APJCP.2015.16.18.8271
|
| 30 |
Jinghua Duan, Yangde Zhang, Shiwei Han, Yuxiang Chen, Bo Li, Mingmei Liao, Wei Chen, Xingming Deng, Jinfeng Zhao, Boyun Huang. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. International Journal of Pharmaceutics 2010; 400(1-2): 211 doi: 10.1016/j.ijpharm.2010.08.033
|
| 31 |
Jonathan Abdelmalak, Natassia Tan, Danny Con, Guy Eslick, Ammar Majeed, William Kemp, Stuart K. Roberts. The Effect of Aspirin Use on Incident Hepatocellular Carcinoma—An Updated Systematic Review and Meta-Analysis. Cancers 2023; 15(13): 3518 doi: 10.3390/cancers15133518
|
| 32 |
Hitomi Hayashi, Eriko Taniai, Reiko Morita, Masahiro Hayashi, Daichi Nakamura, Atsushi Wakita, Kazuhiko Suzuki, Makoto Shibutani, Kunitoshi Mitsumori. Enhanced liver tumor promotion but not liver initiation activity in rats subjected to combined administration of omeprazole and β-naphthoflavone. The Journal of Toxicological Sciences 2012; 37(5): 969 doi: 10.2131/jts.37.969
|
| 33 |
Nasimudeen R. Jabir, Saheem Ahmad, Shams Tabrez. An insight on the association of glycation with hepatocellular carcinoma. Seminars in Cancer Biology 2018; 49: 56 doi: 10.1016/j.semcancer.2017.06.005
|
| 34 |
Natchaya Polpichai, Sakditad Saowapa, Pojsakorn Danpanichkul, Shu-Yen Chan, Leandro Sierra, Johanna Blagoie, Chitchai Rattananukrom, Pimsiri Sripongpun, Apichat Kaewdech. Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma. Journal of Clinical Medicine 2024; 13(22): 6770 doi: 10.3390/jcm13226770
|
| 35 |
Ankita Sahu, Dibyabhaba Pradhan, Babita Veer, Sumit Kumar, Ram Singh, Khalid Raza, Moshahid A. Rizvi, Arun Kumar Jain, Saurabh Verma. In silico screening, synthesis, characterization and biological evaluation of novel anticancer agents as potential COX-2 inhibitors. DARU Journal of Pharmaceutical Sciences 2023; 31(2): 119 doi: 10.1007/s40199-023-00467-x
|
| 36 |
Larissa Widholzer Galant, Ângelo Alves de Mattos, Eduardo Menti, Fabiana Borba Valiatti, Ângelo Zambam de Mattos, Marilene Porawski, Antônio Hartmann, Cláudia Ramos Rhoden. The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats. Annals of Hepatology 2013; 12(3): 425 doi: 10.1016/S1665-2681(19)31005-1
|
| 37 |
Anupam Bishayee, Roslin J. Thoppil, Altaf S. Darvesh, Vahagn Ohanyan, J. Gary Meszaros, Deepak Bhatia. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis. The Journal of Nutritional Biochemistry 2013; 24(1): 178 doi: 10.1016/j.jnutbio.2012.04.009
|
| 38 |
Susan Kralian, Brian I. Carr. Hepatocellular Carcinoma. 2016; : 513 doi: 10.1007/978-3-319-34214-6_34
|
| 39 |
Xu Huang, Xiaoping Zhang, Benyamin Farahvash, Aria F. Olumi. Novel Targeted Pro-Apoptotic Agents for the Treatment of Prostate Cancer. Journal of Urology 2007; 178(5): 1846 doi: 10.1016/j.juro.2007.06.039
|
| 40 |
Chun-Chieh Yeh, Jaw-Town Lin, Long-Bin Jeng, Hsiu J. Ho, Horng-Ren Yang, Ming-Shiang Wu, Ken N. Kuo, Chun-Ying Wu. Nonsteroidal Anti-inflammatory Drugs Are Associated With Reduced Risk of Early Hepatocellular Carcinoma Recurrence After Curative Liver Resection. Annals of Surgery 2015; 261(3): 521 doi: 10.1097/SLA.0000000000000746
|
| 41 |
Teruhime Otoguro, Tomohisa Tanaka, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi. Inhibitory effect of presenilin inhibitor LY411575 on maturation of hepatitis C virus core protein, production of the viral particle and expression of host proteins involved in pathogenicity. Microbiology and Immunology 2016; 60(11): 740 doi: 10.1111/1348-0421.12448
|
| 42 |
Eun-Ji Kim, Gyeoung-Jin Kang, Jung-Il Kang, Hye-Jin Boo, Jin Won Hyun, Young Sang Koh, Weon-Young Chang, Young Ree Kim, Jung-Mi Kwon, Young Hee Maeng, Eun-Sook Yoo, Chang Hoon Lee, Hee-Kyoung Kang. Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cells. Oncotarget 2018; 9(28): 19911 doi: 10.18632/oncotarget.24952
|
| 43 |
Thomas W. Kensler, John D. Groopman, Patricia A. Egner, Alvaro Muñoz, GengSun Qian, JianGuo Chen. Primary Liver Cancer. 2012; : 339 doi: 10.1007/978-3-642-28702-2_11
|
| 44 |
Jessica L. Petrick, Vikrant V. Sahasrabuddhe, Andrew T. Chan, Michael C. Alavanja, Laura E. Beane-Freeman, Julie E. Buring, Jie Chen, Dawn Q. Chong, Neal D. Freedman, Charles S. Fuchs, John Michael Gaziano, Edward Giovannucci, Barry I. Graubard, Albert R. Hollenbeck, Lifang Hou, Eric J. Jacobs, Lindsay Y. King, Jill Koshiol, I-Min Lee, Martha S. Linet, Julie R. Palmer, Mark P. Purdue, Lynn Rosenberg, Catherine Schairer, Howard D. Sesso, Alice J. Sigurdson, Jean Wactawski-Wende, Anne Zeleniuch-Jacquotte, Peter T. Campbell, Katherine A. McGlynn. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project. Cancer Prevention Research 2015; 8(12): 1156 doi: 10.1158/1940-6207.CAPR-15-0126
|
| 45 |
Chun-I Wang, Pei-Ming Chu, Yi-Li Chen, Yang-Hsiang Lin, Cheng-Yi Chen. Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC. International Journal of Molecular Sciences 2021; 22(24): 13627 doi: 10.3390/ijms222413627
|
| 46 |
Carole-Anne Martineau, Nathalie Rivard, Martin Bisaillon. From viruses to cancer: exploring the role of the hepatitis C virus NS3 protein in carcinogenesis. Infectious Agents and Cancer 2024; 19(1) doi: 10.1186/s13027-024-00606-2
|
| 47 |
Qing Chen, Wenjia Lou, Junjie Shen, Leina Ma, Zhi Yang, Li Liu, Jingjing Luo, Cheng Qian. Potent Antitumor Activity in Experimental Hepatocellular Carcinoma by Adenovirus-Mediated Coexpression of TRAIL and shRNA against COX-2
. Clinical Cancer Research 2010; 16(14): 3696 doi: 10.1158/1078-0432.CCR-09-3097
|
| 48 |
Chun‐Chieh Wu, Sheau‐Fang Yang, Wan‐Tzu Chen, Hung‐Pei Tsai, Chi‐Wen Luo, Chee‐Yin Chai, Hsin Ling Yin. Absence of CD66a expression is associated with high microvessel density and high histologic grade in hepatocellular carcinoma. The Kaohsiung Journal of Medical Sciences 2016; 32(6): 306 doi: 10.1016/j.kjms.2016.05.007
|
| 49 |
Manlio Vinciguerra, Michelangelo Foti. PTEN at the crossroad of metabolic diseases and cancer in the liver. Annals of Hepatology 2008; 7(3): 192 doi: 10.1016/S1665-2681(19)31848-4
|
| 50 |
Weiqi Hu, Weimin Xu, Yi Shi, Weijun Dai. lncRNA HOTAIR upregulates COX-2 expression to promote invasion and migration of nasopharyngeal carcinoma by interacting with miR-101. Biochemical and Biophysical Research Communications 2018; 505(4): 1090 doi: 10.1016/j.bbrc.2018.09.190
|
| 51 |
Shanshan Wang, Qian Meng, Qing Xie, Man Zhang. Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells. Molecular Medicine Reports 2017; 15(3): 1179 doi: 10.3892/mmr.2017.6111
|
| 52 |
Eun-Sook Kim, Sun Young Kim, Aree Moon. C-Reactive Protein Signaling Pathways in Tumor Progression. Biomolecules & Therapeutics 2023; 31(5): 473 doi: 10.4062/biomolther.2023.132
|
| 53 |
D Lu, C Han, T Wu. 15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1. Oncogene 2014; 33(9): 1101 doi: 10.1038/onc.2013.69
|
| 54 |
Anupam Bishayee, Roslin J. Thoppil, Animesh Mandal, Altaf S. Darvesh, Vahagn Ohanyan, J. Gary Meszaros, Erzsébet Háznagy‐Radnai, Judit Hohmann, Deepak Bhatia. Black currant phytoconstituents exert chemoprevention of diethylnitrosamine‐initiated hepatocarcinogenesis by suppression of the inflammatory response. Molecular Carcinogenesis 2013; 52(4): 304 doi: 10.1002/mc.21860
|
| 55 |
Melchiorre Cervello, James A. McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto. Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 2012; 3(3): 236 doi: 10.18632/oncotarget.466
|
| 56 |
Ana Hipólito, Sofia C. Nunes, João B. Vicente, Jacinta Serpa. Cysteine Aminotransferase (CAT): A Pivotal Sponsor in Metabolic Remodeling and an Ally of 3-Mercaptopyruvate Sulfurtransferase (MST) in Cancer. Molecules 2020; 25(17): 3984 doi: 10.3390/molecules25173984
|
| 57 |
Lydia Giannitrapani, Sabrina Ingrao, Maurizio Soresi, Ada Maria Florena, Emanuele La Spada, Luigi Sandonato, Natale D'Alessandro, Melchiorre Cervello, Giuseppe Montalto. Cyclooxygenase‐2 Expression in Chronic Liver Diseases and Hepatocellular Carcinoma. Annals of the New York Academy of Sciences 2009; 1155(1): 293 doi: 10.1111/j.1749-6632.2009.03698.x
|
| 58 |
Kyeezu Kim, Yinan Zheng, Brian T. Joyce, Drew R. Nannini, Jun Wang, Yishu Qu, Claudia A. Hawkins, Edith Okeke, Olufunmilayo A. Lesi, Lewis R. Roberts, Demirkan B. Gursel, Fatimah B. Abdulkareem, Alani S. Akanmu, Mary J. Duguru, Pantong Davwar, David Paul Nyam, Rahmat A. Adisa, Godwin Imade, Jian-Jun Wei, Masha Kocherginsky, Kwang-Youn Kim, Wasiu L. Adeyemo, Emuobor Odeghe, Firas H. Wehbe, Chad Achenbach, Atiene Sagay, Folasade Ogunsola, Robert L. Murphy, Lifang Hou. Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV. Hepatology International 2024; doi: 10.1007/s12072-024-10768-1
|
| 59 |
Jeong Won Jang. Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor. The Korean Journal of Hepatology 2008; 14(3): 305 doi: 10.3350/kjhep.2008.14.3.305
|
| 60 |
Shuhuai Wang, Xinmei Kang, Shouqiang Cao, Hui Cheng, Di Wang, Jingshu Geng. Calcineurin/NFATc1 Pathway Contributes to Cell Proliferation in Hepatocellular Carcinoma. Digestive Diseases and Sciences 2012; 57(12): 3184 doi: 10.1007/s10620-012-2255-8
|
| 61 |
Azra Memon, Yuliya Pyao, Yerin Jung, Jung Il Lee, Woon Kyu Lee. A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(15): 5461 doi: 10.3390/ijms21155461
|
| 62 |
Maria Teresa Rizzo. Cyclooxygenase-2 in oncogenesis. Clinica Chimica Acta 2011; 412(9-10): 671 doi: 10.1016/j.cca.2010.12.026
|
| 63 |
Mattia Acito, Ina Varfaj, Virginia Brighenti, Emine Ceren Cengiz, Tommaso Rondini, Cristina Fatigoni, Carla Russo, Donatella Pietrella, Federica Pellati, Desirée Bartolini, Roccaldo Sardella, Massimo Moretti, Milena Villarini. A novel black poplar propolis extract with promising health-promoting properties: focus on its chemical composition, antioxidant, anti-inflammatory, and anti-genotoxic activities. Food & Function 2024; 15(9): 4983 doi: 10.1039/D3FO05059A
|
| 64 |
Vikrant V. Sahasrabuddhe, Munira Z. Gunja, Barry I. Graubard, Britton Trabert, Lauren M. Schwartz, Yikyung Park, Albert R. Hollenbeck, Neal D. Freedman, Katherine A. McGlynn. Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma. JNCI: Journal of the National Cancer Institute 2012; 104(23): 1808 doi: 10.1093/jnci/djs452
|
| 65 |
Mattia Acito, Martina Palomba, Cristina Fatigoni, Milena Villarini, Luca Sancineto, Claudio Santi, Massimo Moretti. Fagiolina del Trasimeno, an Italian cowpea landrace: effect of different cooking techniques and domestic storage on chemical and biological features. International Journal of Food Science & Technology 2022; 57(10): 6557 doi: 10.1111/ijfs.15998
|
| 66 |
Anupam Bishayee, Abhijeet Waghray, Kendra F. Barnes, Thomas Mbimba, Deepak Bhatia, Malay Chatterjee, Altaf S. Darvesh. Suppression of the Inflammatory Cascade is Implicated in Resveratrol Chemoprevention of Experimental Hepatocarcinogenesis. Pharmaceutical Research 2010; 27(6): 1080 doi: 10.1007/s11095-010-0144-4
|
| 67 |
Mohammed A. El-Magd, Yasser Mohamed, Eman S. El-Shetry, Shafika A. Elsayed, Maha Abo Gazia, Ghada A. Abdel-Aleem, Noha M. Shafik, Walied S. Abdo, Nabila I. El-Desouki, Mohamed A. Basyony. Melatonin maximizes the therapeutic potential of non-preconditioned MSCs in a DEN-induced rat model of HCC. Biomedicine & Pharmacotherapy 2019; 114: 108732 doi: 10.1016/j.biopha.2019.108732
|
| 68 |
Verónica G. Piazza, María E. Matzkin, Nadia S. Cicconi, Nadia V. Muia, Sofía Valquinta, Gregorio J. Mccallum, Giannina P. Micucci, Thomas Freund, Elsa Zotta, Lorena González, Mónica B. Frungieri, Yimin Fang, Andrzej Bartke, Ana I. Sotelo, Johanna G. Miquet. Exposure to growth hormone is associated with hepatic up-regulation of cPLA2α and COX. Molecular and Cellular Endocrinology 2020; 509: 110802 doi: 10.1016/j.mce.2020.110802
|
| 69 |
Wen Chen, Jian-Bing Wang, Christian C. Abnet, Sanford M. Dawsey, Jin-Hu Fan, Liang-Yu Yin, Jian Yin, Philip R. Taylor, You-Lin Qiao, Neal D. Freedman. Association between C-Reactive Protein, Incident Liver Cancer, and Chronic Liver Disease Mortality in the Linxian Nutrition Intervention Trials: A Nested Case–Control Study. Cancer Epidemiology, Biomarkers & Prevention 2015; 24(2): 386 doi: 10.1158/1055-9965.EPI-14-1038
|
| 70 |
Mamdouh M Ali, Ibrahim H Borai, Hala M Ghanem, Abeer H Abdel-Halim, Fatma M Mousa. The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesis. Biomedicine & Pharmacotherapy 2018; 98: 491 doi: 10.1016/j.biopha.2017.12.096
|
| 71 |
Wei-Bing Li, Yang Li, Chen Yu, Yong-Ming He. Reversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR Cells. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/390812
|
| 72 |
Anna Santarsiero, Paolo Convertini, Dominga Iacobazzi, Vittoria Infantino, Simona Todisco. Metabolic Crossroad Between Macrophages and Cancer Cells: Overview of Hepatocellular Carcinoma. Biomedicines 2024; 12(12): 2684 doi: 10.3390/biomedicines12122684
|
| 73 |
Li-Jie Wang, Li Bai, Dan Su, Ting Zhang, Zhi-Yuan Mao. Proinflammatory conditions promote hepatocellular carcinoma onset and progression via activation of Wnt and EGFR signaling pathways. Molecular and Cellular Biochemistry 2013; 381(1-2): 173 doi: 10.1007/s11010-013-1700-0
|
| 74 |
Alessandra Ammazzalorso, Stefania Tacconelli, Annalisa Contursi, Ulrika Hofling, Carmen Cerchia, Sara Di Berardino, Alessandra De Michele, Rosa Amoroso, Antonio Lavecchia, Paola Patrignani. A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1488722
|
| 75 |
Hyunjoo Lee, Joshua S. Trott, Shabirul Haque, Steven McCormick, Nicholas Chiorazzi, Patricia K. A. Mongini. A Cyclooxygenase-2/Prostaglandin E2 Pathway Augments Activation-Induced Cytosine Deaminase Expression within Replicating Human B Cells. The Journal of Immunology 2010; 185(9): 5300 doi: 10.4049/jimmunol.1000574
|
| 76 |
Santanu Maji, Sabindra K Samal, Laxmipriya Pattanaik, Swagatika Panda, Bridget A. Quinn, Swadesh K. Das, Devanand Sarkar, Maurizio Pellecchia, Paul B. Fisher, Rupesh Dash. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas. Oncotarget 2015; 6(18): 16623 doi: 10.18632/oncotarget.3932
|
| 77 |
Maria Grazia Refolo, Caterina Messa, Vito Guerra, Brian Irving Carr, Rosalba D’Alessandro. Inflammatory Mechanisms of HCC Development. Cancers 2020; 12(3): 641 doi: 10.3390/cancers12030641
|
| 78 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3443 doi: 10.1007/978-3-319-26956-6_186
|
| 79 |
Kyu-Hwa Lee, Seok-Chul Yang. Relation between Cyclooxygenase-2 and Polo-like Kinase-1 in Non-Small Cell Lung Cancer. Tuberculosis and Respiratory Diseases 2009; 67(4): 303 doi: 10.4046/trd.2009.67.4.303
|
| 80 |
V. Sivaramakrishnan, S. Niranjali Devaraj. Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chemico-Biological Interactions 2009; 180(3): 353 doi: 10.1016/j.cbi.2009.02.004
|
| 81 |
Magda Hamzawy, Laila Elsaid, Asmaa Shams, Laila Rashid, Soheir Mahfouz, Nivin Sharawy. Study of the Effects of Cyclooxygenase-2 Inhibitor on the Promotion of Hepatic Tumorigenesis in Rats Fed a High Fat Diet. Journal of Clinical and Experimental Hepatology 2015; 5(1): 14 doi: 10.1016/j.jceh.2014.12.010
|